Study of Safety of RVL-1201 in Treatment of Blepharoptosis

See also
Status	Clinical Trial	Phase
Completed	`NCT00864656` - Eyelid Position Interdependence in Involutional Ptosis Patients Submitted to 10% Phenylephrine	N/A
Recruiting	`NCT02959697` - Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair	N/A
Recruiting	`NCT02501187` - Risk of Dry Eye Post Different Surgeries for Blepharoptosis Repair	N/A
Completed	`NCT00793988` - Vibration-Assisted Anaesthesia	Phase 4
Completed	`NCT02367677` - Digital Photographs to Evaluate Blepharoptosis	N/A
Recruiting	`NCT01239498` - Saline Injection - Assisted Anesthesia in Eyelid Surgery	Phase 4
Not yet recruiting	`NCT05358977` - Fibrin Sealant in Eyelid Surgery	Phase 2/Phase 3
Completed	`NCT01848041` - Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis	Phase 1/Phase 2
Completed	`NCT01350024` - Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid	N/A
Completed	`NCT06047418` - Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation
Active, not recruiting	`NCT03149367` - Surgical Management of Blepharoptosis	N/A
Completed	`NCT03565887` - Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis	Phase 3
Recruiting	`NCT01968174` - Astigmatic Changes Secondary to Eyelid Surgeries	N/A
Active, not recruiting	`NCT04678115` - Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis	N/A
Not yet recruiting	`NCT04235803` - Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery	N/A
Completed	`NCT02988856` - Magnetic Correction of Eye Lid Paralysis	N/A
Terminated	`NCT03239418` - NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy	N/A
Not yet recruiting	`NCT02638610` - Assessment of Changes of Periocular Skin Sensation Following Eyelid and Ocular Surface Surgeries	N/A
Enrolling by invitation	`NCT05945615` - Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis	Phase 3
Recruiting	`NCT06292182` - Red Light Ptosis Proof-of-Concept	N/A

NCT number	NCT03536949
Study type	Interventional
Source	RVL Pharmaceuticals, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	June 20, 2018
Completion date	March 27, 2019

Study of Safety of RVL-1201 in Treatment of Blepharoptosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms